In a letter to the new UK Prime Minister Keir Starmer, leading figures in industry and academia have called for a plan to turn the Oxford-Cambridge region into the 'crown jewel' of the nati
Clinical trials are strictly regulated to ensure patient safety, but the current framework in the UK is stifling early-phase clinical research, making it harder to advance novel therapies t
While the headlines are all about the Labour landslide in the UK general election this morning, Wes Streeting, who has been shadow health secretary in opposition and may well have the equiv
A new code of practice has been drawn up in the UK to try to make sure that research on human embryo models derived from stem cells is carried out ethically and responsibly.
The Association of the British Pharmaceutical Industry (ABPI) is calling on political parties contesting the general election to spell out their plans to nurture and drive growth in t
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh